Birdwatch Note
2024-10-30 02:52:18 UTC - NOT_MISLEADING
La creatina cuenta con múltiples estudios que avalan su efectividad, incluso metanálisis. https://pmc.ncbi.nlm.nih.gov/articles/PMC5679696/
Written by DA5480723CBC1C058F11E291E8E6EAD5545A8C5522B961D9C18C5CBA39731461
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1851344925499023812
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1851457070064660485
- noteId - 1851457070064660485
- participantId -
- noteAuthorParticipantId - DA5480723CBC1C058F11E291E8E6EAD5545A8C5522B961D9C18C5CBA39731461
- createdAtMillis - 1730256738569
- tweetId - 1851344925499023812
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- La creatina cuenta con múltiples estudios que avalan su efectividad, incluso metanálisis. https://pmc.ncbi.nlm.nih.gov/articles/PMC5679696/
Note Ratings
| rated at | rated by | |
| 2024-10-31 11:53:25 -0500 | Rating Details | |
| 2024-10-31 11:06:48 -0500 | Rating Details | |
| 2024-10-30 16:10:10 -0500 | Rating Details | |
| 2024-10-30 13:07:15 -0500 | Rating Details | |
| 2024-10-30 13:01:10 -0500 | Rating Details | |
| 2024-10-30 11:12:39 -0500 | Rating Details | |
| 2024-10-30 10:27:50 -0500 | Rating Details | |
| 2024-10-30 10:23:47 -0500 | Rating Details | |
| 2024-10-30 09:44:18 -0500 | Rating Details | |
| 2024-10-30 09:25:04 -0500 | Rating Details | |
| 2024-10-30 08:22:32 -0500 | Rating Details | |
| 2024-10-30 08:13:32 -0500 | Rating Details | |
| 2024-10-30 07:38:06 -0500 | Rating Details | |
| 2024-10-30 07:07:41 -0500 | Rating Details | |
| 2024-10-30 06:22:31 -0500 | Rating Details | |
| 2024-10-30 06:18:25 -0500 | Rating Details | |
| 2024-10-30 06:03:50 -0500 | Rating Details | |
| 2024-10-30 00:30:15 -0500 | Rating Details | |
| 2024-10-29 22:02:10 -0500 | Rating Details | |
| 2024-10-31 09:49:03 -0500 | Rating Details | |
| 2024-10-30 21:44:54 -0500 | Rating Details | |
| 2024-10-30 20:30:00 -0500 | Rating Details | |
| 2024-10-30 20:21:00 -0500 | Rating Details | |
| 2024-10-30 16:46:49 -0500 | Rating Details | |
| 2024-10-30 14:06:34 -0500 | Rating Details | |
| 2024-10-30 12:24:55 -0500 | Rating Details | |
| 2024-10-30 11:46:17 -0500 | Rating Details | |
| 2024-10-30 10:17:45 -0500 | Rating Details | |
| 2024-10-30 08:05:12 -0500 | Rating Details | |
| 2024-10-30 08:03:20 -0500 | Rating Details | |
| 2024-10-30 06:39:30 -0500 | Rating Details | |
| 2024-10-30 05:21:13 -0500 | Rating Details | |
| 2024-10-30 03:33:15 -0500 | Rating Details | |
| 2024-10-30 02:18:45 -0500 | Rating Details | |
| 2024-10-30 02:12:51 -0500 | Rating Details | |
| 2024-10-29 23:54:33 -0500 | Rating Details | |
| 2024-10-29 23:12:17 -0500 | Rating Details | |
| 2024-10-29 22:29:59 -0500 | Rating Details | |
| 2024-10-30 21:24:35 -0500 | Rating Details | |
| 2024-10-30 18:17:27 -0500 | Rating Details | |
| 2024-10-30 17:38:49 -0500 | Rating Details | |
| 2024-10-30 13:57:07 -0500 | Rating Details | |
| 2024-10-30 12:54:16 -0500 | Rating Details | |
| 2024-10-30 11:17:22 -0500 | Rating Details | |
| 2024-10-30 07:57:34 -0500 | Rating Details | |
| 2024-10-30 07:38:58 -0500 | Rating Details | |
| 2024-10-30 05:44:38 -0500 | Rating Details | |
| 2024-10-30 00:23:58 -0500 | Rating Details | |
| 2024-10-30 00:09:04 -0500 | Rating Details | |
| 2024-10-29 22:53:14 -0500 | Rating Details | |
| 2024-10-31 08:55:48 -0500 | Rating Details | |
| 2024-10-30 14:33:25 -0500 | Rating Details | |
| 2024-10-30 12:31:34 -0500 | Rating Details | |
| 2024-10-30 12:15:40 -0500 | Rating Details | |
| 2024-10-30 10:33:35 -0500 | Rating Details | |
| 2024-10-30 10:23:25 -0500 | Rating Details | |
| 2024-10-30 08:23:18 -0500 | Rating Details | |
| 2024-10-30 06:39:10 -0500 | Rating Details | |
| 2024-10-30 05:45:44 -0500 | Rating Details | |
| 2024-10-30 05:14:39 -0500 | Rating Details | |
| 2024-10-30 02:22:32 -0500 | Rating Details | |
| 2024-10-30 01:24:18 -0500 | Rating Details | |
| 2024-10-30 00:31:06 -0500 | Rating Details | |
| 2024-10-29 23:41:38 -0500 | Rating Details | |
| 2024-10-30 21:43:52 -0500 | Rating Details | |
| 2024-10-30 20:58:52 -0500 | Rating Details | |
| 2024-10-30 20:51:59 -0500 | Rating Details | |
| 2024-10-30 20:07:10 -0500 | Rating Details | |
| 2024-10-30 09:26:21 -0500 | Rating Details | |
| 2024-10-30 06:05:58 -0500 | Rating Details | |
| 2024-10-30 02:48:58 -0500 | Rating Details | |
| 2024-10-30 02:46:28 -0500 | Rating Details | |
| 2024-10-30 00:47:33 -0500 | Rating Details |